Your session is about to expire
← Back to Search
Pulmonary Artery Catheter for Cardiogenic Shock (PACCS Trial)
PACCS Trial Summary
This trial is testing whether or not a PAC (a type of heart monitor) can help improve outcomes for patients with heart failure who are in cardiogenic shock.
PACCS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPACCS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PACCS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a condition called cardiogenic shock, which is identified by specific test results showing high lactate levels and other specific measurements.I am on the waiting list for a heart transplant.You have a "do not resuscitate" or "do not intubate" status.Your blood tests show a high INR level, a low platelet count, or low hemoglobin levels.You are pregnant, gave birth within the last 6 months, or are breastfeeding.I do not have severe heart valve disease or heart infection.You have a confirmed ongoing infection with a persistent fever or bacteria in your blood.You have a condition that makes it unsafe for you to have a PAC (peripherally inserted central catheter) placed.I have a heart condition from birth, but it's not a bicuspid aortic valve.I have heart failure with specific issues in my heart's left side.My shock is not due to left heart failure.I am on dialysis before joining the study.I have had a stroke or brain bleeding, or I have a condition that increases my risk of brain bleeding.I had heart surgery within the last 3 months.I have a history of heart amyloidosis.You have had a pacemaker or defibrillator implanted in the last 3 months.You have a mechanical problem related to a heart attack.You tested positive for COVID-19 in the past 4 weeks.I am scheduled for heart surgery during my hospital stay.I was moved to this hospital with a diagnosis of severe heart failure.My condition is a type of high blood pressure that affects the arteries in my lungs and heart.I have had a heart attack that did not respond to treatment within the last day.I have suffered a brain injury due to lack of oxygen.I am between 18 and 90 years old.I was hospitalized for COVID-19 but have been symptom-free for at least 4 weeks.You have a long-term ventricular assist device or temporary mechanical circulatory support.I do not have any health conditions expected to shorten my life to under 6 months, aside from heart failure.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- Group 1: Early Pulmonary Artery Catheter
- Group 2: No or delayed Pulmonary Artery Catheter
Frequently Asked Questions
What criteria must a potential participant fulfill in order to be accepted into this clinical trial?
"This clinical trial is seeking 400 patients with cardiogenic shock, aged between 18 and 90. The individuals must meet certain criteria for their participation to be valid, including: systolic blood pressure (SBP) lower than 90 mmHg from the baseline reading; a left ventricular ejection fraction of 40% or less as reported by an echocardiogram within 24 hours before screening; at least one vasopressor/inotrope being used in treatment; an intra-aortic balloon pump providing support during care; evidence of congestion such as enlarged jugular vein on physical examination, pulmonary edema noted in"
Does this research extend to senior citizens?
"For this specific trial, participants must be aged 18 - 90. Concerning other trials, 35 are catering to minors and 818 cater specifically to those over 65 years of age."
Is enrollment into this trial still possible for prospective participants?
"Evidently, this clinical trial is no longer actively accepting candidates as the posting on clinicaltrials.gov has not been updated since September 25th 2022. Nonetheless, there are currently 838 other studies that do require additional participants."
Share this study with friends
Copy Link
Messenger